EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access

Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases: Systematic Review and Meta-Analysis

Schätzung unerwünschter Ereignisse bei pflanzlichen Arzneimitteln anhand von Pharmakovigilanz-Datenbanken: systematische Übersicht und Metaanalyse

Chuenjid Kongkaew iD, Dang Thuc Anh Phan iD, Prathan Janusorn iD, Pajaree Mongkhon iD

JMIR Public Health and Surveillance · 29.08.2024 · 10 · e63808

DOI: 10.2196/63808 ↗

Auf einen Blick

26 Studien zeigen eine große Spannweite der Melderate unerwünschter Ereignisse bei pflanzlichen Arzneimitteln. Die gepoolte Schätzung lag bei 1,42 %.

Fragestellung

Welche Melderate unerwünschter Ereignisse bei pflanzlichen Arzneimitteln ergibt sich aus Pharmakovigilanz-Datenbanken, und welche Detaildaten enthalten die Berichte?

Methode

Systematische Übersicht und Metaanalyse; Suche in MEDLINE/PubMed, SCOPUS, EMBASE und CINAHL bis Dezember 2023; Pooling mit Random-Effects-Modell; Heterogenität per Subgruppen-, Meta-Regression und Sensitivitätsanalyse.

Ergebnisse

26 Studien. Die Melderate lag zwischen 0,03 % und 29,84 %; gepoolte mediane Gesamtschätzung 1,42 % (IQR 1,12 %–1,72 %). Die Melderate war mit der Quelle der meldenden Person assoziiert (P=.01).

Einschränkungen

Keine vollständigen Angaben zu den verdächtigten pflanzlichen Produkten; nur Hauptinhaltsstoffe wurden genannt, weitere potenziell schädliche Bestandteile nicht.

Schlussfolgerung der Autor:innen

Die Übersichtsarbeit zeigt Risiken pflanzlicher Arzneimittel mit breiter Spannweite der Melderaten je nach Melderquelle. Die Autor:innen betonen Standardisierung und bessere Qualitätssicherung der Meldesysteme.

Kernaussagen

  • Gepoolte Melderate: 1,42 %
  • Spannweite von 0,03 % bis 29,84 %
  • Melderate hing von der Melderquelle ab (P=.01)

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Metaanalyse in der Zeitschrift JMIR Public Health and Surveillance, online erschienen am 29.08.2024. Verfasst von Chuenjid Kongkaew und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Safety and Quality in Health, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thail…. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions, Plant Preparations. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Herbal medicines (HMs) are extensively used by consumers/patients worldwide. However, their safety profiles are often poorly reported and characterized. Previous studies have documented adverse events (AEs) associated with HMs, such as hepatotoxicity, renal failure, and allergic reactions. However, the prevalence rate of AEs related to HMs has been reported to be low. To date, no systematic review and meta-analysis has comprehensively analyzed the AEs of HMs using published data acquired from pharmacovigilance (PV) databases.

Objective

This study aimed to (1) estimate the reporting rate of the AEs of HMs using PV databases and (2) assess the detailed data provided in AE reports.

Methods

In this systematic review and meta-analysis, MEDLINE/PubMed, SCOPUS, EMBASE, and CINAHL were systematically searched for relevant studies (until December 2023). The DerSimonian-Laird random effects model was used for pooling the data, and subgroup analyses, the meta-regression model, and sensitivity analysis were used to explore the source of heterogeneity. Crombie’s checklist was used to evaluate the risk of bias (ROB) of the included studies.

Results

In total, 26 studies met the eligibility criteria. The reporting rate of the AEs of HMs ranged considerably, from 0.03% to 29.84%, with a median overall pooled estimate of 1.42% (IQR 1.12%-1.72%). Subgroup analyses combined with the meta-regression model revealed that the reporting rate of the AEs of HMs was associated with the source of the reporter (P=.01). None of the included studies provided full details of suspected herbal products, only the main ingredients were disclosed, and other potentially harmful components were not listed.

Conclusions

This systematic review and meta-analysis highlighted risks related to HMs, with a wide range of reporting rates, depending on the source of the reporter. Continuous efforts are necessary to standardize consumer reporting systems in terms of the reporting form, education, and follow-up strategy to improve data quality assurance, aiming to enhance the reliability and utility of PV data for monitoring the safety of HMs. Achieving effective monitoring and reporting of these AEs necessitates collaborative efforts from diverse stakeholders, including patients/consumers, manufacturers, physicians, complementary practitioners, sellers/distributors, and health authorities. Trial Registration PROSPERO (Prospective International Register of Systematic Reviews) CRD42021276492

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsPlant PreparationsHumansDatabases, FactualHerbal MedicinePharmacovigilance

Stichwörter der Autor:innen

adverse eventherbal medicinemeta-analysispharmacovigilancespontaneous reporting system

Substanzen

Plant Preparations

Autor:innen und Institutionen

  • Centre for Safety and Quality in Health, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.
  • Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University College London, London, United Kingdom.
  • Faculty of Pharmacy, Hue University of Medicine and Pharmacy, Hue City, Vietnam.
  • Pharmacy Department, Soidao Hospital, Chantaburi, Thailand.
  • School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand.

ORCID-Profile: Chuenjid Kongkaew, Dang Thuc Anh Phan, Prathan Janusorn, Pajaree Mongkhon

Zitieren

APA

Kongkaew, C., Phan, D. T. A., Janusorn, P., & Mongkhon, P. (2024). Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases: Systematic Review and Meta-Analysis. JMIR Public Health and Surveillance, 10, e63808. https://doi.org/10.2196/63808

Vancouver

Kongkaew C, Phan DTA, Janusorn P, Mongkhon P. Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases: Systematic Review and Meta-Analysis. JMIR Public Health and Surveillance. 2024;10:e63808. doi:10.2196/63808

BibTeX
@article{Kongkaew2024,
  author = {Kongkaew, Chuenjid and Phan, Dang Thuc Anh and Janusorn, Prathan and Mongkhon, Pajaree},
  title = {Estimating Adverse Events Associated With Herbal Medicines Using Pharmacovigilance Databases: Systematic Review and Meta-Analysis},
  journal = {JMIR Public Health and Surveillance},
  year = {2024},
  volume = {10},
  pages = {e63808},
  doi = {10.2196/63808}
}
Kostenlos starten →